Twist Bioscience Corporation TWST Reportable Segment — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — total costs & expenses?
- Twist Bioscience Corporation (TWST) reported reportable segment — total costs & expenses of $156.58M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — total costs & expenses changed year-over-year?
- Twist Bioscience Corporation's reportable segment — total costs & expenses increased by 16.5% year-over-year, from $134.35M to $156.58M.
- What does reportable segment — total costs & expenses mean?
- Aggregates all operating costs, including cost of goods sold, research, and administrative overhead, incurred by the reportable segment. This metric is essential for evaluating the total cost structure and the overall operational burden of the segment.